Form 4: BioCardia CEO Peter Altman Acquires Additional Shares

BioCardia's President and CEO, Peter Altman, recently purchased 600 shares of the company's common stock at an average price of $2.48 per share.

Summary

• On February 7, 2025, Peter Altman, the President and CEO of BioCardia, Inc., acquired 600 shares of common stock.
• The purchase was made at a weighted average price of $2.48 per share, with individual trades ranging from $2.37 to $2.50.
• Following the transaction, Altman directly owns 107,920 shares of BioCardia's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase suggests confidence, but it's a small transaction and doesn't provide definitive insight.

Positives

• The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. This purchase could be seen as a positive sign, but should be considered in conjunction with other factors.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

BioCardia, BCDA, Peter Altman, stock purchase, Form 4, insider trading, common stock